Cell2B was featured at Reuters as one of the companies that facing the current crisis in Portugal with Technology aiming at a global market. The story shows a path to economic growth based on new business and higher goals. Complete article here.
Cell2B was featured at OJE, an open access economics journal in Portugal. The story covered in dept the company’s progression and future. You can see the complete story here.
New Position@Cell2B: Quality Control Technician. Please check the minimum requirements here!
Cell2B is now preparing submission for clinical trials of a new cell therapy. This is a great opportunity to join our dynamic team!
Pedro Andrade and Francisco Santos were the guests of the national radio show Geração XXI. Francisco and Pedro explained the project from inception to the current stage. This program focuses on the new generation that will help Portugal to surpass the current economic climate. Listen to the entire show here.
Daniela Couto was invited to speak at the Science Business promoted debate on Entrepreneurship entitled Can EU = Entrepreneurship Union? Daniela elaborated on the importance of entrepreneurship for the union’s future and some limitation that need to be surpassed to foster new ventures in Europe. More information here.
Cell2B was invited for the morning news clip at eTV. At this show the company’s current stage and future were approached. Discussion was centered mainly on the business side. Full interview here.
Cell2B was featured at Boletim de Biotecnologia, the report from the Portuguese Biotechnology Association (here). This is a vision of the future of the sector in Portugal.
Cell2B participated in the Bosch Foundation meeting on Science Policy – Berlin Debate on Science Policy. Daniela Couto attended this private meeting to define new policies for European Science Policy. More Information here.
Cell2B was featured at Diário Económico a leading business newspaper in Portugal. This was part of the BES management for entrepreneurs intensive course at Universidade Católica Portuguesa that Daniela Couto and David Braga Malta are attending (link).
Cell2B was featured at RTP. A short report on the development of the company’s leading technology ImmuneSafe and the Everis Award. More information here (min 7.40).
Cell2B wins the Everis Foundation Second Prize 40.000 euro award. This award is a recognition of the potential of the project and ImmuneSafe – Cell2B’s leading technology – to address an highly unmet medical need. This was the first time a Portuguese company as distinguished by the Everis Foundation. More information here.
Cell2B was featured in Portugal Marca, a National TV show that focused on entrepreneurial projects (here min. 7.40). This program highlights Cell2B’s leading technology ImmuneSafe.
Cell2B was featured on National TV in a showcase of Life Sciences Entrepreneurial projects. Falar Global is a leading technology show in Portugal. This showcase follows and initial program on the development of Cell2B’s leading technology ImmuneSafe. More information here.
Daniela Couto was a speaker at GreenFest. Daniela spoke on “Entrepreneurship as the Attitude” engaging with a trilling audience. More information here.
First stage of recruitment is now closed. Selected candidates will be called for interviews. All candidates will be informed of the decision.
Cell2B is looking for motivated professionals across several areas to join the project. If you are interested please look in the careers section for further details.
Cell2B was feature in a leading finance newspaper in Portugal in a section on entrepreneurship and new business ideas in Portugal (link).
Daniela Couto attended TiE Lisbon held at the city Municipality. In this event participated a total of 170 members of TiE Global, a network that is spread all over the world with 57 chapters across 14 countries.
Daniela Couto will be the invited entrepreneur today at Beta-talk. This is an event organized by Beta-i monthly to inspire, share experiences, and networking. Today it will take place in Lisbon, at Pavilhão do Conhecimento, at 7:30 pm.
Go the website and book your spot! Hope to see you there!
Cell2B was featured at a leading business newspaper as a innovation and entrepreneurship case in healthcare. (link)
Cell2B was granted today the SME status with EMA. The SME status confers to Cell2B reduced fees with EMA and expedite procedures.
Cell2B was featured on National TV in one of the most renown programs on science and technology. This was a great overview of the company and its’ goals. (Full video here, in Portuguese)
Cell2B was awarded the €25000 A2B/BluePharma award in the ArriscaC Business Plan Competition. This competition had more that 150 participants at the national level. This award reinforces our strategy and motivation to pursue our goals. (video)
Cell2b was chosen as a finalist in the Academic Enterprise Awards. It is the first time that a Portuguese spin-off and University are represented in this award. The final round will be in Royal Academy of Sciences in Brussels during next month. This will be an unique opportunity to look for investment in Europe. Find the ACES press release here.
Cell2B is featured today in the Portuguese Newspaper “Diário de Notícias”. The newspaper highlights our key goal for this year: start a clinical in Europe to treat transplanted patients and avoid organ rejection.
Please find the entire article here “Esperança para doentes de leucemia espera investidores”.